GU Cancers 2023 | Will liquid biopsy-based approaches replace traditional pathological markers for bladder cancer?

Kyle M. Rose, MD, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, discusses whether liquid biopsy-based approaches will replace traditional pathological markers in bladder cancer. this interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.